Roy Exum: My Pimples And Andrea Sloan

Monday, September 30, 2013 - by Roy Exum
Roy Exum
Roy Exum

A real long time ago I was having a fit with acne. I was a lovelorn teenager, infatuated with pretty girls in a dizzy game where pimples can really become cumbersome. It seemed like nothing was working and, after I grew a pimple large enough for its own zip code, I finally found a genius doctor who quickly became my lifelong hero when he came up with a marvelous idea.

At the time there was a new “super drug”  that was languishing through years of “clinical trials” in the United States and nobody could get any, despite the fact the revolutionary medicine was already available in Germany. My hero called up a close friend who was a German doctor and – presto! – the first 250 pills came flying across the ocean.

I had to promise that I would not sue anybody if I grew an extra set of ears, developed female breasts, or my eyes turned yellow, but, honestly, I would have dyed my hair green to get the American-made medicine. After I took a course of what was then identified by only a strange laboratory number, my pimples and my acne were gone forever. I had Clark Gable looks and never looked back. That’s a true story (except the Gable part.)

Other fellow Americans had to wait for many months. I don’t believe that's right. Since this occurred in my formative years, I have cursed the federal Food and Drug Administration for much of my adult life because the “clinical trials” process we use is horribly dysfunctional and in critical need of an overhaul.

To illustrate my point, allow me to introduce a beautiful Texas lawyer, Andrea Sloan. Yes, she is quite pretty but “beautiful” because her career has been as the executive director of a Texas advocacy project that provides free legal services to low-income victims of domestic or sexual abuse.

Andrea is a victim herself, not just of stage 3c ovarian cancer but a horribly-tangled FDA system. Her doctors have exhausted every known method to save her life. Six years of surgery, radiation, and chemotherapy haven’t worked. She’s still very much a patient at the world-famous M.D. Anderson Medical Center and her oncologist believes an experimental drug called “BMN 673” might well save Andrea’s life.

M.D. Anderson has a good supply of BMN 673 on hand but with millions of dollars at stake, the manufacturer, BioMarin in California, has said no. “It would be unethical and reckless to provide end-stage refractory ovarian cancer patients outside clinical trial with BMN 673 at this early stage of development,” said spokesperson Debra Charlesworth.

“If we did,” Charlesworth explained to CNN, “we would be exposing the experimental drug to a large group without adequate testing. There have been previous circumstances where early access to large groups has resulted in adverse consequences that were worse than the course of the disease.”

I am certain no scientist can hardly wait for somebody to try to explain to me what “adverse consequences” could possibly be worse than what Andrea Sloan is facing without BMN 673. Andrea is pleading for the drug – let the petals of the flower fall where they may – and probably understands the risks as much as anyone involved. She knows what will happen if she fails to get BMN 673 better than anyone else, too.

Here is what she wrote in a statement to the drug company: “I recognize the importance of weighing the risk and the myriad of considerations they face as a company. However, this is a risk worth taking. I will thank them. My family will thank them. An amazing army of loyal supporters, to whom I owe a debt of gratitude, will thank them. In America we do not leave our wounded warriors on the battleground. BioMarin, please be the Calvary that saves me.”

Her M.D. Anderson doctors believe Andrea is a great candidate. Further, the FDA itself has just announced Ms. Sloan qualifies for a “compassionate care” waiver in the rules but the manufacturer, BioMarin, still says no. The word is BioMarin stands to make about $500 million on the drug and, even though they say they plan to give away 10 percent of the medicine to charity, they refuse to face the ethical dilemma.

As of Sunday afternoon Andrea had almost 170,000 supporters on her Change.org webpage and politician Newt Gingrich, co-host of CNN’s “Crossfire” program, is irate at “a corporation protecting its wallet at the expense on Andrea’s possibly dying. If you want to know why big companies often get bad names, it’s explaining that clerical support to fill out FDA paperwork is too difficult when you can save a life.”

Dr. Charles Levenback, Andrea’s doctor, is disappointed at BioMarin’s stance but, as a man who sees the fight against cancer every day, he told CNN reporters, “My own belief is that the drug companies, the manufacturers, the insurance companies, the providers like my hospital M.D. Anderson, the individual medical professionals, the investigators, the patients -- everybody wants the same things. Safe, effect, novel therapies for as many people as it's appropriate for. Even BioMarin, I believe. I don't think this is like 'Let the masses eat cake.' I think they're on the same mission. But the whole system is giving this dysfunctional result."

On Andrea Sloan’s Facebook page there is a picture that tells of “Three Simple Rules.” The text reads, “If you don’t go after what you want in life, you will never have it. If you don’t ask, the answer will always be No. If you don’t step forward, you’ll always be in the same place.”

Those three rules got rid of my pimples but all we can do is pray for Andrea Sloan. She needs it right now.

royexum@aol.com


Send Your Opinions To Chattanoogan.com

We welcome your opinions at Chattanoogan.com. Email to news@chattanoogan.com . We require your real first and last name and contact information. There is no word limit, but if your article is too long you may lose your reader. Please focus more on issues than personal attacks. (click for more)

Remembering The Sober Auschwitz Facts

Seventy years ago today Auschwitz concentration camp was liberated. Sober to consider the facts. May we stand against this in every way in every decision we make. Imagine taking everyone in Nashville, Chattanooga and Knoxville... Imprisoning them and killing them in a camp. That's how many died there. That's everyone you work with, all your friends, their children, your whole ... (click for more)

Chief Fletcher Gives Maximum Punishment To Patrol Officer Who Fired 4 Shots Toward Vehicle That Backed Toward Him

Chattanooga Police Chief Fred Fletcher has given a maximum punishment to an officer who fired four shots toward a vehicle after he said the driver backed into his vehicle with him standing behind it. Chief Fletcher sustained a finding of “improper use of force – discharge of firearm.” He suspended Officer Alex Olson for 30 days without pay – the maximum suspension allowed ... (click for more)

Van Found On Its Side Off Burkhalter Gap Road; Woman's Remains Nearby; May Be Trenton Woman Missing Since June 4

A van was found on its side off Burkhalter Gap Road on the side of Lookout Mountain near Trenton, Ga., on Wednesday with a woman's body nearby. Authorities said the woman may be a missing Trenton woman. Justine Marie Creech had been missing since June 4. The discovery was made by a woman out hiking. A skull and remains were near the rear tire, authorities said.  ... (click for more)

Libby Peigen Named Soddy-Daisy Volleyball Coach

Libby Peigen, daughter of Ooltewah coach Elaine Peigen, has been named head volleyball coach at Soddy-Daisy, replacing Lorri Johnson. Peigen had been head middle school and assistant varsity coach at East Hamilton before taking over the Lady Trojans' program. She played volleyball at Ooltewah and Lee University. The announcement of Peigen's hiring was originally posted ... (click for more)

UTC Softball Team Prepares for 2015 Season

It’s nine days to the season opener – Plainsman Invite (Auburn, Ala.) – and the UTC Indoor Softball Facility at Warner Park was alive with the sounds of batting and infield practice Wednesday afternoon as the 20 Lady Moc players plus coaches were on hand for 2015 Media Day. Located in their familiar spot as pre-season Southern Conference favorites, UTC returns a strong ... (click for more)